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ABSTRACT 
The use of natural products have become popular because of their minimal adverse effect, cost effectiveness and accessibility. 
Moringa oleifera, is a valued plant that has found use ethnomedicinally and economically. The leaves have been investigated in 
various researches for different activities. This study is aimed at evaluating the seeds for its serum lipid profile altering activities 
in animal models. Five groups of five animals (120-150 g) per group were made obese by feeding with a high fat diet (HFD) for 
10 weeks. The basal lipid profile was determined, and treatment commenced with methanol extracts of Moringa oleifera seed 
(MOSE) at 100 and 200 mg/kg b w for 6 weeks. Control groups were the Orlistat treated (50 mg/kg b w), untreated and normal 
diet groups. The antihyperlipidemic activity in-vivo and an enzyme anti lipase assay in-vitro were determined respectively. The 
characterisation of isolated compounds and derivative was by spectroscopic techniques. A significant decrease in Very Low 
Density Lipoprotein cholesterol (VLDLc) at p< 0.01 was observed across the five groups when compared with the standard 
Orlistat. A significant increase in High Density Lipoprotein cholesterol (HDLc) at p< 0.01 was observed in the group treated 
with 200 mg/kg MOSE. However, a dangerous significant increase in Athereogenic index (AI) was observed in the group treated 
with 100mg/kg MOSE The derived 4- acetyl benzylisothiocyanate-O –α-L rhamnopyranoside (2) from isolated 4- 
hydroxybenzylisothiocyanate-O-α-L rhamnopyranoside (1) revealed the highest activity of 99.17% at 0.5 mg/mL. The methanol 
extract of Moringa oleifera seed could alter lipid profile and a structure activity relationship was observed with respect to the 
isolated compound and its derivatized analogue. 
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INTRODUCTION 
 
Hyperlipidemia is a heterogeneous group of disorders 
characterized by high level of lipids in the bloodstream. These 
lipids include cholesterol, cholesterol esters, phospholipids, 
and triglycerides.  Alternatively, the disease refers to elevated 
levels of lipids and cholesterol in the blood, or the 
manifestations of different disorders of lipoprotein 
metabolism (dyslipidemia). Hyperlipidemia is associated with 
increased levels of atherogenic lipoproteins, which is a 
contributing factor and primary indicators of atherosclerosis, 
susceptibility to coronary heart disease (CHD) and 
cerebrovascular accidents as well as enhanced oxidative stress 
in hepatocytes, renal tissue and inflammatory reactions 
(Suanarunsawat et al., 2011). 
 Previous studies evaluated activities of Moringa plant 
where the aqueous extract of leaves particularly was reported 
for wound healing (Rathi et al., 2006) and antiurolithiasis 
activity (Karadi et al., 2006). The methanolic crude extract of 
M. oleifera shows antibacterial activity (Nantachit, 2006) 
while the bark extract has been shown to possess antifungal 
and anti-tubercular activity (Bhatnagar et al., 1961). The 
ethanolic and aqueous extract were found to be hypotensive 
(Faizi et al., 1998). The leaves have also been evaluated for its 
anti-nutrient (Jain et al., 2010; Mehta et al., 2003), antioxidant 
(Ryter et al., 2007; Limon-Pacheco and Gonsebatt, 2009) and 
anti-inflammatory (Rana et al., 2007) properties. Extracts 
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from M. oleifera leaves have also been shown to modulate 
humoral and cellular immunity in rats and mice (Gupta et al., 
2010; Sudha et al., 2010). These properties have been more 
extensively studied with fruit and seed extracts (Cheenpracha 
et al., 2010) with little reference to its relation to 
hyperlipidemia. 
 Currently, no pharmacological treatment provides 
sustained weight loss with minimal adverse effects (Hasani-
Ranjbar et al., 2013). Literature review has revealed that 
various herbal plants such as Cleistopholis patens (Udem et 
al, 2011), Vernonia amygdalina (Oluwatosin et al., 2008), 
Parkia biglobosa (Odetola et al., 2006), Nigella sativa, 
Camellia sinensis, Green Tea, and Black Chinese Tea 
(Bhishagratna et al., 1991) are used in the management of 
hyperlipidemia.  Previous researches reported that Moringa 
oleifera leaves contain phytosterols such as β-sitosterol (Jain 
et al., 2010) which works by reducing intestinal uptake of 
dietary cholesterol (Lin et al., 2010).  However, Moringa 
oleifera seeds have not been evaluated for its 
antihyperlipidemic potential through the reduction of 
intestinal uptake of dietary cholesterol or lipase inhibition.  
This study sought to investigate the antihyperlipidemic 
activity of the seeds and its isolated bioactive constituents 
through lipase inhibition mechanism. 
 
MATERIALS AND METHODS 
 
Plant materials  
The seeds of Moringa oleifera were obtained from Ibadan 
metropolis, Nigeria in May 2013. The authentication was done 
by Mr T.K Odewo of the Forest Herbarium Ibadan where 
voucher specimen (FHI 110098) was deposited. 
 
Extraction 
Air-dried and blended Moringa oleifera seed (500 g) was 
extracted by cold maceration in 95 % methanol for 72 h. The 
extract was filtered and concentrated by the rotary evaporator 
to give a 40 g yield of the methanol extract. 
 
In vitro anti lipase activity on extract and isolates 
Inhibition of lipase was determined using a modified assay 
described by Smeltzer et al., 1992. A suspension containing 
1% (v/v) of Glyceryl trioleate, and 1% (v/v) Tween 40 in 0.1 
M phosphate buffer (pH 8) was prepared and emulsified. 
Assays were then initiated by adding 800 μL of the Glyceryl 
trioleate emulsion to 200 μL of porcine pancreatic lipase (0.5 
gm pancreatin in 15 mL 0.1 M phosphate buffer at pH 8.0) and 
200 μL of fraction (or 0.1 M Phosphate buffer, pH 8). The 
contents were mixed and the absorbance measured 
immediately at 450 nm and designated as T0. The test tubes 
were incubated at 37°C for 30 mins and at the end of the 
incubation; the absorbance at 450 nm was recorded and 
designated as T30. 
The variation in absorbance was calculated for both control 
and the treatment and the % inhibition was calculated using 
the formula: 
% inhibition =  
 ([A450Control - A450Extract] / A450Control) × 100 
Incubation at 37⁰C, pH 8.9 for 1 h and Absorbance measured 
at 340 nm in triplicates.  
Experimental animals 
Twenty-five wistar rats (120-150 g) were purchased from the 
Vet Animal House, University of Ibadan. Nigeria and kept 
under standard environmental conditions.  
They were grouped into 5 groups of 5 rats in a group. 
Group 1: 100 mg/kg MOSE co-administered along with High 
fat diet (HFD)  
Group 2: 200 mg/kg MOSE co-administered with High fat diet 
(HFD). 
Group 3: Orlistat (standard) 50 mg/kg body weight was co-
administered with (HFD). 
Group 4: Untreated control rat group maintained on a high fat 
diet throughout the experiment. 
Group 5: Untreated control rat group maintained on normal 
standard chow diet and water ad libitum throughout the 
experiment. 
 They were fasted for 14 h all night before the experiment. 
The animal experimental protocol was in conformity with the 
Ethics Committee Guidelines of the University of Ibadan with 
ethical approval number (UI-ACUREC/17/0105) as well as 
the US guidelines of internationally accepted principles for 
laboratory animal use and care. Animals were also treated in 
agreement with OECD guidelines for testing of chemicals 
(NIH publication #85-23, 1985).  
 
In vivo lipase inhibitory assay of Extracts 
In this study, a total of twenty-five rats were used and divided 
into five groups of 5 rats each. Groups 1-4 were fed a high fat 
diet continuously for 10 weeks before treatment with varying 
doses of MOSE. Group 5 rats were maintained on standard 
chow diet and water ad libitum for 16 weeks but were not 
treated.  
 Body weights were monitored weekly and animals were 
sacrificed at the end of the experiment. Capillary tubes were 
used to collect blood sample from the retro-orbital venous 
sinus of the rats into lithium heparinized bottles. The blood 
samples collected was centrifuged at 3000 rpm for 20 mins to 
obtain plasma separated for estimation of lipid profile 
including total cholesterol (TC), High density lipoprotein 
cholesterol(HDLc), Low density lipoprotein cholesterol 
(LDLc), Very low density lipoprotein cholesterol (VLDLc), 
Triglycerides (TG) and Atherogenic index (AI) by enzymatic 
colorimetric reactions methods using commercial kits 
(Randox). 
 
Chromatographic purification of fraction 
Moringa oleifera seed methanol extract (MOSE 40g) was 
subjected to vacuum liquid chromatography (VLC) using 1.5 
L each of n-hexane, dichloromethane, ethylacetate and 
methanol in increasing polarities to elute. A total number of 
100 fractions were collected and pooled (by TLC monitoring) 
into 4 pooled fractions 1-11(hexane), 12-
17(dichloromethane), 18-38 (ethylacetate) and 39 
(Aq/methanol) were subjected to in-vitro lipase inhibitory 
assay.  
The most active VLC fraction 18-38 (ethylacetate) of MOSE 
(9g) was dissolved in methanol, the solvent was allowed to 
evaporate from the adsorbed material before introducing into 
a column (internal diameter 3.5 cm and 53 cm long) packed  
Lipid altering potentials of Moringa oleifera seed extracts 
 
79 Afr. J. Biomed. Res. Vol. 23, No.1 (January) 2020 Ajayi et al 
with silica gel (230-400 mesh) in hexane. Elution was with 
acetone: hexane mixtures in increasing polarities.  
 Fractions (200 mLs each) were collected and separately 
concentrated to dryness in vacuo using a rotary evaporator.  
Fraction 11 (eluted with acetone 100%) afforded compound 1, 
a UV active and a golden yellow crystal, which was 
derivatized by acetylation to afford compound 2.  
 
Statistical Analysis 
Data were analysed using one way analysis of variance 
(ANOVA) followed by Turkeys multiple comparison pair and 
Student t test was used to determine the difference between 
the control and individual test groups. Results were presented 
as Mean ± SEM, and the differences were considered 




There was a significant increase in weight of the untreated 
groups when compared to the treated groups (Table 1). The 
In- vitro lipase inhibitory activity of the extrasct is shown in 
Table 2. 
 
Effect of extract on lipid profile parameters in treated rats 
and control groups: A significant reduction in Total 
Cholesterol (TC) at p<0.05 was observed in the groups of rats 
treated with Moringa 100 mg/kg (87.92 mg/dL) and Orlistat 50 
mg/kg (81.49 mg/dL) as compared to the HFD group (111.24 
mg/dL). However, the reduction in TC in the other treatment 
group (Moringa 200 mg/kg) was not statistically significant 
(Fig 1).  
 The treatment groups (Moringa 100 mg/kg and 200 mg/kg) 
revealed a significant increase in High density lipoprotein 
cholesterol HDLc when compared to the Orlistat treated group 
(Fig 2). The increase was significant in the Moringa 200 mg/kg 
treated group at p<0.01 when compared to the three control 
groups suggesting a dose dependent activity. 
Table 1    
Determination of percentage mean weight increase of 





















3.07 3.08 1.05 44.23 36.70 
Key 
HFD-  High fat diet 
MOSE- Moringa oleifera seed extract 
 
Table 2.  
In- vitro lipase inhibitory activity of plant extract compared to 
reference standard 





Moringa oleifera seed 0.445 ± 0.146 36.0 
Orlistat 1.35 ± 0.004 57.0 
      % Inhibition=Acontrol-Aextract/Acontrol   x 100 
 
 A non-significant decrease in low density lipoprotein 
cholesterol (LDLc) was observed in the moringa treated 
groups although to different degrees which suggests a dose 
dependent activity (fig 3). The Normal diet group, however 
revealed an expected reduction in LDLc level that is 
significantly different from the other two control groups (HFD 
and Orlistat 50 mg/kg). 
 The treatment groups Moringa 100 mg/kg and 200 mg/kg, 
significantly reduced the VLDLc levels at p< 0.01 (fig 4) 
when compared to Orlistat 50 mg/kg treatment group 




Figure 1.  
Effect of Moringa seed extract on Total Cholesterol 
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Figure 2.  
Effect of Moringa seed extract on High density lipoprotein cholesterol (HDLc) 
 
 
Figure 3.  
Effect of moringa seed extract on low density lipoprotein cholesterol (LDLc)  
 
 
Figure 4.  
Effect of Moringa seed extract on Very low density lipoprotein cholesterols (VLDLc) 
 
According to lipid hypothesis, atherogenic index is an 
indication of the degree of deposition of foam cells or plaque 
or fatty infiltration or lipids in heart, coronaries, aorta, liver 
and kidneys. The higher the atherogenic index, the higher the 
risk of CHD (Idemudia et al., 2013). The increase observed in 
atherogenic index in the moringa 100 mg/kg treatment group 
was statistically significant at p<0.05 when compared to the 
normal diet group (fig 5). This is a pointer to a risk that should 
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be double checked despite all some other parameters revealing 
significant reduction. 
 It was also observed that the triglyceride level (TG) was 
significantly higher in the orlistat treated group (143.20 
mg/dL) (fig 6) when compared to other control groups HFD 
(88.82 mg/dL) and normal diet (76.20 mg/dL) suggesting that 
TG was not hydrolysed as lipase which normally should 
hydrolyze Triglycerides (TG) to free fatty acids and stored as 
fat was effectively inhibited. However, the TG levels in 
Moringa treated groups at 100 mg/kg (75.65 mg/dL) and 200 
mg/kg (65.08 mg/dL) were not significantly different from the 
control groups which could be due to the differences in the 
mechanism of action of moringa extracts and that of the 
standard drug. 
 
Isolation of compounds from Moringa oleifera 
Compound 1: 1H-NMR spectral data (CD3OD, 500 MHZ)   δppm ;  1.20 
(d, 3H, H-6´), 3.30 (s, 2H, H-7), 3.45(t, 1H, H-5´), 3.65(m, 1-OH, H-
4´), 3.80(t, 1-OH, H- 3´), 4.00 (s, 1-OH, H- 2´), 5.40 (s, 1H, H- 1´), 
7.10 (dd, 2H, H-3, H-5), 7.30 (dd, 2H, H-2, H-6).  
ESI-MS m/z (% relative intensity) 311 (M+, 100). Accurate mass 
measurement; Found:311.0511,  C14H17NO5S requires 311.3534.  
  
Compound 2: 1H-NMR spectral data (CD3OD, 500 MHZ)   δppm ;  0.9 
(m, 3H, H-6´), 1.20 (m, 2H, H-7), 2.1(m, 1H, H-5´), 3.7(s, 2-
OCOCH3, H-4´), 3.95(s, 1-OH, H- 3´), 5.15 (d, 1-OH, H- 2´), 5.50 
(m, 2H, H- 1´), 7.10 (dd, 2H, H-3, H-5), 7.30 (dd, 2H, H-2, H-6).  
ESI-MS m/z (% relative intensity) 438 [M++H], accurate mass 
measurement; Found:437.1439,  C20H23NO8S requires 437.1469. 
 
Figure 5.  




Figure 6  
Effect of Moringa seed extract on Triglycerides (TG) 





Besides the use of synthetic orthodox hypolipidemic drugs 
(Eliot and Jamali, 1999; Ochani and D’mello, 2009), 
numerous plant extracts have been previously demonstrated to 
possess anti-hyperlipidemic effects in animal models in vivo 
(Al-Dosari, 2011; Raghuveer et al., 2011; Suanarunsawat et 
al., 2011; Giri et al., 2012; Durendic-Brenesel et al., 2013; 
Kaur and Meena, 2013). The findings in this study are 
supported by several previous studies in which the therapeutic 
potentials of the plant extracts have been attributed to their 
phytochemical and nutritive contents. Accordingly, 
phytochemical studies by previous researches have revealed 
the presence of bioactive principles in Moringa oleifera 
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involved in readjustment of lipid metabolism to the advantage 
of experimental animals (Kumar et al., 2012). 
Table 3: 
13CNMR of compound 1 in comparison with published data 
Carbon 
number 
Cpd 1 Reported data( Faizi et al., 1994) 
1 156.41 156.03 
2,6 117.05 116.65 
3,5 129.31 129.23 
4 124.79 132.64 
7 21.7 22.9 
8 118.8 123.72 
1´ 98.82 97.96 
2´ 72.78 70.9 
3´ 71.20 71.7 
4´ 70.98 73.5 
5´ 69.69 68.8 
6´ 17.01 17.5 
 
Table 4: 
13CNMR of compound 2 in comparison with published data  
Carbon 
number 
Cpd 2 Reported data 
(Consolacion et al., 2012) 
1 155.52 156.65 
2, 6 129.24 129.25 
3, 5 116.83 116.87 
4 124.00 131.70 
7 22.88 22.91 
8 116.95 123.70 




3´ 70.83                           70.13 
4´ 68.80                            75.49 
5´ 67.25                           66.36 
6´ 17.40                           17.46 
OAc 170.06                         172.01 
OAc 169.96                         172.01 
OAc 20.88                           21.05 
 
Table 5:   
In vitro antilipase activity of isolated compounds 














O-α-L- rhamnopyranoside (2) 
94.21 99.17 
3 Orlistat® (Control) 67.98 54.00 
























Figure 7:   
























Figure 8:  
4- acetyl benzylisothiocyanate-O –α-L rhamnopyranoside (2) 
 
The phytochemical screening of the crude methanolic extract 
of Moringa oleifera seed has been reported by Ogunjinmi et 
al. 2012, to contain alkaloids, flavonoids, saponins, and 
steroids, which confer several biological properties. Saponins 
have been demonstrated to possess hypocholesterolemic 
property and effectiveness in the control of high blood 
pressure associated with hyperlipidemia (Oakenfull and 
Sidhu, 1990) 
 A general increase in the mean weight of the experimental 
animals was observed throughout the experiment, especially 
the High Fat Diet (HFD) groups indicating the expected effect 
of the High Fat Diet on the animals. However, the percentage 
weight increase in the Moringa treated groups is comparable 
to the Orlistat treated group suggesting some management in 
the weight increase when compared to the untreated group 
after the experiment. The untreated group on normal diet 
however, maintained a steady minimum increase in weight 
throughout the experiment as expected as shown in Table 1. A 
comparable percentage lipase inhibition was observed in the 
Moringa oleifera seed when compared to Orlistat, the 
reference standard as shown in Table 2. 
 The disparity in the significant reduction observed in Total 
Cholesterol in the two treated groups as compared to the HFD 
group suggests that the TC lowering activity could be dose 
dependent. This finding is supported by previous researches 
that established phytosterols, specifically β-sitosterol to 
possess blood cholesterol-lowering activity by impeding 
intestinal cholesterol absorption routes and has inhibitory 
action on hepatic cholesterol biosynthetic pathways (Duester, 
2001; Mayes and Botham, 2003). Expectedly, the intake of 
plant materials rich in β-sitosterol results in reduction in total 
serum cholesterol levels in the experimental animals 
(Moghadasian and Frohlich, 1999; Al-Dosari, 2011).  
 The observed elevation of HDLc in rats administered 
Moringa oleifera however, indicates its beneficial effect 
against cardiovascular disease as HDLc  is secreted by the 
liver and intestinal cells where it removes excess cholesterol 
from circulation and carries it back to the liver where 
degradation or conversion into bile acids takes place (Rahilly, 
2011).  
 A non-significant decrease in low density lipoprotein 
cholesterol (LDLc) observed in the moringa treated groups 
suggests a dose dependent activity. The Normal diet group, 
however revealed an expected reduction in LDLc level that is 
significantly different from the other two control groups (HFD 
and Orlistat 50 mg/kg). This corroborates the fact that 
consumption of a HFD will result in a high LDLc level and 
accumulating evidence over the last decades had linked 
elevated total cholesterol and low-density lipoprotein-
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cholesterol (LDLc) levels and reduced HDL levels to the 
development of Coronary heart disease (CHD) (Segal et al., 
1972). 
 Very low density lipoprotein cholesterols (VLDLc) are 
triglyceride-rich lipoproteins, but contains 10–15 % of the 
total serum cholesterol (Howell et al., 1997). The major 
apolipoproteins of  VLDLc are apo B-100, apo Cs (C-I, C-II, 
and C-III), and apo E. VLDLc are produced by the liver and 
are precursors of LDLc; some forms of VLDLc, particularly 
VLDLc remnants, appear to promote atherosclerosis, similar 
to LDL (Howell et al., 1997).  The treatment groups Moringa 
100 mg/kg and 200 mg/kg, significantly reduced the VLDLc 
levels at p< 0.01 when compared to Orlistat 50 mg/kg 
treatment group supporting the claim of Moringa seed 
antihyperlipidemic activity. 
 The overall result points to the fact that Moringa oleifera 
seed extract possess a dose independent relationship all 
through the study. This could be attributable to some factors 
which could include experimental errors as well as biological 
variation in response of animals tested. Of note is the 
observation in the groups treated with both doses (100 and 200 
mg/kg) revealing a significant decrease at p<0.01 in TG and 
VLDLc levels when compared to the control group on orlistat. 
The group treated with 100 mg/kg MOSE showed a significant 
decrease of AI at p<0.05 when compared to the control  group 
on normal diet, while the group treated with 200 mg/kg  of 
MOSE showed a significant decrease of HDL at p< 0.01 when 
compared to all the control groups. However, the two treated 
groups showed no significant change in LDLc when compared 
to controls. There was an observation of a high atherogenic 
index which is used as a diagnostic indicator when the other 
risk parameters appear normal (Nwagha and Igweh, 2005). 
These observations may be due to pharmacokinetics of 
gastrointestinal absorption of extract which may also change 
with increased dose of extract administered leading to a fall in 
the absorption rate which in turn affects the desired effect. At 
other times doubling the dose of extract administered may lead 
to a decrease in effect other than doubling the tissue 
concentration of a particular sample under testing (Veng-
Pedersen et al., 1991). 
 Compound 1 have also been isolated from Moringa 
stenopetala (Faizi et al., 1994) and Noccaea caerulenscens 
(Rob et al., 2014). It is the rhamnose derivative of sinalbin (4- 
hydroxybenzyl glucosinate) (Amaglo et al., 2010; Bennette et 
al., 2003). The 13CNMR spectra (Table 3) indicated that there 
are 14 carbon atoms present. The signal identified as due to a 
methyl carbon and the most shielded carbon atom (δ 17.0) in 
the 13CNMR is assignable to C-5´ located on the rhamnose 
sugar.  This is closely followed by a methylene (δ 21.7).The 
13CNMR spectra also revealed the presence of five methine 
carbons  assignable to C-1´, C-2´, C-3´, C-4´ and C-5´ all 
located on the rhamnose moeity. The methine carbon assigned 
as C-1´ (δ 98.82) is an anomeric carbon linking the rhamnose 
to the benzene ring. There are four other methine carbons 
appearing on the benzene ring and are assigned as C-2 and C-
6(δ 129.31), C-3 and C-5 (δ 117.05). The most de- shielded is 
assigned to C-2 and C-6 δ 129.31 due to the proximity to the 
C-1 which directly links the oxygen atom connecting the 
rhamnose. The spectra also revealed the presence of three 
quaternary carbons appearing at δ 156.41, 124.79 and 118.85 
assignable to C-1, C-4 and C-8.  
 These assignments were further supported by comparison 
with reported data (Faizi et al., 1994). The presence of 
oxygenated groups at δ 3.3, 3.45, 3.65 and 3.8 in the 1HNMR 
is further confirmed in the 13CNMR with signals appearing at 
δ 117.05 assignable to C-3 and C-5, δ 118.85 ppm assignable 
to C-8, δ 124.79 ppm assignable to C-4 and δ 129.31 
assignable to C-2 and C-6. The 500 MHz 1HNMR spectra 
signals in CD3OD revealed the presence of a para substituted 
aromatic benzene ring in the molecule at 7.1 (d, J= 8.7Hz) and 
7.3 (d, J =8.6Hz).  Other protons include 3 protons doublet at 
signal δ 1.2 (J=6.2 Hz) which is due to the methyl group on 
the rhamnose. 
 Compound (2) was obtained as a yellow substance by the 
acetylation of compound 1. It was identified as 4- acetyl 
benzylisothiocyanate-O –α-L rhamnopyranoside (2) (Fig viii) 
with a melting point of 236 ᵒC (Lit m.pt 234ᵒC) (Consolacion 
et al., 2012) and a molecular formula of C20H23NO8S. The 
accurate mass found was 437.1439 while the calculated mass 
is 437.1469.  The 13C NMR (Table 4) confirms the presence 
of equivalent carbon atoms  (δ 20.76 and 29.67) shifted more 
downfield than normal as in the parent compound assignable 
to the carbon atoms of the acetate attached to ( C-2´, C-3´ and 
C-4´). The presence of 1,4 disubstituted benzene ring was also 
confirmed by resonances  at δ 116.8 (C-3 and C-5) and 129.2( 
C-2 and C-6). The presence of a carbonyl group of the acetate 
was observed at δ 170.064ppm assignable carbons attached to 
C- 2´, C- 3´ and C-4´.  
 The 13CNMR reveals the presence of three quatenary 
carbons resonating at δ 155.52, 124.00 and 116.95 assignable 
to  C-1, C-4 and C-8 with the most de-shielded resonating at δ 
155.52. This suggests that the position of the anomeric carbon 
(δ 95.6 assigned C-1´) of the glycoside was attached to the 
benzene ring through this carbon. The least de-shielded 
quatenary carbon is that attached to the sulphur and Nitrogen 
because of the pulling effect on the carbon which leaves it 
electron deficient. 
 The oxygenated methine protons were assigned to 
resonances at δ 70.8, 69.6, 68.8 and 67.2 assigned as C-5´, C-
4´, C-3´and C-2´. The methylene carbon resonance appeared 
at δ 17.4 assignable to C-6´, the acetate signals appear at δ 
20.88 assignable to the carbonyl attached to C-3´ and δ 170.06 
and 169.96 assignable to the carbonyl attached to  C-2´ and C-
4´ and are more de-shielded due to their proximity to the 
oxygen atom linking the rhamnose to the benzene ring. The 
13C NMR spectra indicated that there are 20 carbon atoms 
present as methyls, (OMe) and (CMe). There are three 
quaternary carbons at δ 155.5, 124.0 and 116.95 assignable to 
C-1, C-4 and C-8. This was further confirmed by comparing 
data with already reported data (Consolacion et al., 2012). 
A signal at 1.3 (d) ppm of the 1HNMR data was assigned to 
the CH3 group of rhamnose (C-6´). The 500MHz 1HNMR 
spectra signals in CD3OD revealed the presence of a para 
substituted benzene ring in the molecule at 7.1 (d, J =8.7 Hz) 
and 7.3 (d, J= 8.6 Hz). The proton is shifted more downfield 
than normal and appears as a doublet as it is coupling with the 
C-2´ proton (δ 170.06 ppm). 
 The in-vitro lipase inhibitory evaluation of isolates as 
shown in Table 5 revealed that Compound 2, resulting from 
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the derivatization of the naturally occurring compound 1 gave 
the highest lipase inhibitory activity of 99.17% at 0.5 mg/mL 
and 94.21% at 0.25 mg/mL when compared to the Orlistat® 
control at both concentrations (54% at 0.5 mg/mL and 67.98% 
0.25 mg/mL). This suggests a structure activity relationship 
between the active derivatized compound 2 and the isolated 
compound 1 which showed no activity. The derivatized 
compound (2) is however, being reported for 
antihyperlipidemic activity in this study thereby validating the 
hypolipidemic claim in ethnomedicine. 
 In conclusion, results here are comparable to previous 
research in which rats with induced hyperlipidemia were used 
where aqueous leaf extract of Moringa oleifera demonstrated 
an ameliorative effect on lipid profile (Pratik et al., 2013) and 
is attributed to its potential to control the mechanisms 
involved in lipids elimination from the body (Naznin et al., 
2008). This study revealed that Moringa oleifera at lower 
doses of 100 mg/kg and 200 mg/kg, were able to alter the 
serum lipid profile although may be ameliorative and at the 
same time aggravative and to different degrees. Summarily, 
the use of the seed of Moringa oleifera should be with some 
caution as supported by claims from previous researches 
(Ajayi et al., 2016). It may however, be a potent template or 
lead for future lipid altering agents.  
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